Axol's next phase of growth will expand its U.S. operations and development in response to increasing global customer demand.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...

Proveris is a global provider for spray characterization testing instrumentation, lab services and OINDP expertise ...

Johnson & Johnson, a global healthcare company, is expanding in Wilson County, North Carolina via a new multibillion-dollar ...

Kincell Bio, a contract development and manufacturing organization (CDMO), has promoted three executives to strengthen its ...

The DXR3 SmartRaman+ is designed to detect defects or contaminants while preserving sample integrity.

Bayer is acquiring two investigational molecular imaging agents from Attralus for the diagnosis of cardiac amyloidosis.

The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.

XCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has appointed Steve Smith as CEO.

Veristat, a global clinical research organization and consultancy, has named Kim McLean Boericke as its Chief Executive Officer (CEO).